Skip to main content
  • Login
Home

User menu

Mega menu

  • EASL
  • Resources

    Resources

    • EASL Resources
      • All Resources
      • Basic Techniques in Experimental Hepatology at a Glance
      • Clinical Practice Guidelines
      • Congress Resources
      • COVID-19 Resources
      • EASL Molecular Tumour Boards
      • EASL Policy Dialogues
      • EASL Quiz
      • ePosters
      • EASL DeepDive
      • EASL Journal Club
      • Nurses and AHPs
      • Online Courses
      • On-demand Webinars
      • Podcasts
      • Slide Decks
      • Webcasts
      • Webinars Calendar
    • EASL-Related Resources
      • EHC On-demand Webinar
      • ERN Rare-Liver On-demand Webinars
      • Baveno VII - Consensus Workshop
      • Baveno VII - Pediatric Research Workshop
    • Industry Resources
      • All Resources
      • Industry Symposia - EASL Monothematic Conference 2023
      • Industry Symposia - International Liver Congress
      • Industry Symposia - Liver Cancer Summit
      • Industry Symposia - NAFLD Summit 2022
      • GSK Resources
    • Patient Resources
      • All Resources
      • COVID-19 Resources
      • Documents
      • ePosters
      • Infographics
      • Patient Guidelines
      • Podcasts
      • Slide Decks
      • Takeaways
      • Webcasts
  • EASL Studio
  • EASL Campus Connect
    • My Community
    • Explore Community
      • EASL Community Feed
      • All Topics
      • Community FAQ's
    • Create
  • Our Sponsors

EASL Community Feed

Get the latest news from the EASL Community

Newest topics

Hepatitis C Point of Care Testing
Gavin Hooper-Newton · 6 Feb
Welcome to EASL Campus Connect!
Elinam Gayi · 20 Jun
All topics

  • Christian Molina-Aguilar posted

    1 month ago

  • Margaret Vernon commented on EASL Studio - Deciphering the dr…

    2 months ago

    EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention (Complete Session)

    EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention   Debbie Shawcross (Moderator), Paolo Angeli (Faculty), Salvador Augustin (Boehringer Ingelheim representative), Paolo Caraceni (CSL Behring representative) This EASL Studio is supported by Boehr...
    Total amount of likes 0
    Total amount of comments 2
    Read more about EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention (Complete Session)
    Log in to post comments
    Margaret Vernon
    Margaret Vernon • 2 months ago

    Excellent discussion - very informative - thank you

    Like
    1 like
    Dislike 0
    Reply
    Anonymous
    Margaret Vernon
    Margaret Vernon • 2 months ago

    Excellent discussion - very informative - thank you

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous

  • Luis Rodriguez commented on TIPS and ascites (Complete Sessi…

    2 months ago

  • ABU SALEH MD SADEQUL ISLAM commented on Non-alcoholic fatty liver diseas…

    3 months ago
    Non-alcoholic fatty liver disease: A patient guideline

    Non-alcoholic fatty liver disease: A patient guideline

    This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of unawareness. Furthermore, many aspects of the disease are still to be unravelled, which ha...
    Total amount of likes 2
    Total amount of comments 1
    ABU SALEH MD S… • 3 months ago

    EASY LANGUAGE

    Like
    1 like
    Dislike 0
    Reply
    Anonymous

  • ABU SALEH MD SADEQUL ISLAM commented on Liver Cancer Explained

    3 months ago
    Liver Cancer Explained

    Liver Cancer Explained

    Liver cancer is the third leading cause of cancer-related deaths worldwide and the primary cause of death for patients with cirrhosis. Most of liver cancers are hepatocellular carcinomas, however some patients develop intrahepatic cholangiocarcinomas (ICC) or rare tumours in non-cirrhotic livers. Chronic liver diseases, alcohol c...
    Total amount of likes 1
    Total amount of comments 1
    ABU SALEH MD S… • 3 months ago

    EXCELLENT SUMMARIZE

    Like
    1 like
    Dislike 0
    Reply
    Anonymous

  • ABU SALEH MD SADEQUL ISLAM commented on ILC 2021 Takeaways – Public heal…

    3 months ago
    ILC 2021 Takeaways – Public health

    ILC 2021 Takeaways – Public health

    As part of the International Liver Congress (ILC) 2021, the EASL Takeaways take a look at key topics from the congress, with leading experts discussing the most impactful science and putting it into perspective. This session, presented by Professors Maria Buti, Shira Zelber-Sagi and Antonio Craxì, explores prominent themes f...
    Total amount of likes 1
    Total amount of comments 1
    Read more about ILC 2021 Takeaways – Public health
    Log in to post comments
    ABU SALEH MD S… • 3 months ago

    EXCELLENT DISCUSSION

    Like
    1 like
    Dislike 0
    Reply
    Anonymous

  • 元春 刘 posted

    3 months ago

  • LUIZ OTAVIO Cangussu posted

    3 months ago

  • LUIZ OTAVIO Cangussu posted

    3 months ago

  • ABU SALEH MD SADEQUL ISLAM commented on EASL Clinical Practice Guideline…

    3 months ago
    EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy

    EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy

    Liver diseases in pregnancy comprise both gestational liver disorders and acute and chronic hepatic disorders occurring coincidentally in pregnancy. Whether related to pregnancy or pre-existing, liver diseases in pregnancy are associated with a significant risk of maternal and fetal morbidity and mortality. Thus, the European Ass...
    Total amount of likes 0
    Total amount of comments 1
    ABU SALEH MD S… • 3 months ago

    EXCELLENT

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous

  • Rehana Begum commented on Mycophenolate Mofetil as first l…

    4 months ago

  • Vincenzo Mazzaferro commented on EASL Studio - Advances in system…

    4 months ago

    EASL Studio - Advances in systemic treatments in liver cancer (Complete Session)

    EASL Studio - Advances in systemic treatments in liver cancer   Josep Llovet (Moderator), Massimo Iavarone (Faculty), Matthias Pinter (Faculty), Jessica Zucman-Rossi (Faculty)
    Total amount of likes 0
    Total amount of comments 1
    Read more about EASL Studio - Advances in systemic treatments in liver cancer (Complete Session)
    Log in to post comments
    Vincenzo Mazzaferro
    Vincenzo Mazzaferro • 4 months ago

    😊

    Like
    1 like
    Dislike 0
    Reply
    Anonymous

  • mohamed abdiaziz posted

    4 months ago

  • Rahim Khan commented on EASL Studio S6 E12: Do we care e…

    4 months ago
    EASL Studio S6 E12: Do we care enough about the importance of DILI/DHILI ?

    EASL Studio S6 E12: Do we care enough about the importance of DILI/DHILI ?

    Description Join us for a critical discussion on the significance of Drug and Herbal & Dietary Supplement-Induced Liver Injury (DHILI). In this episode, the speakers explore the importance of DHILI, assess recent advancements, and deliberate on the obstacles hindering further progress in addressing this pressing healthcare c...
    Total amount of likes 0
    Total amount of comments 1
    Read more about EASL Studio S6 E12: Do we care enough about the importance of DILI/DHILI ?
    Log in to post comments
    Rahim Khan
    Rahim Khan • 4 months ago

    Can I discuss a case and get opinion's from expert when to consider liver biopsy ?

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous

  • Gavin Hooper-Newton commented on Hepatitis C Point of Care Testin…

    8 months ago
    Hepatitis C Point of Care Testing

    Hepatitis C Point of Care Testing

    Created on
    6 Feb 2024 •
    by
    Gavin Hooper-Newton
    Total amount of likes 0
    Total amount of comments 1
    Read more about Hepatitis C Point of Care Testing
    Gavin Hooper-Newton • 8 months ago

    Please feel free to complete and share my masters research survey for informing development of a systemized community and non-regulated workforce approach to enabling HCV POCT training, testing and linking to care https://forms.gle/tAw6mpct6AnDgstq7

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous

  • Gavin Hooper-Newton created a topic

    8 months ago

    Hepatitis C Point of Care Testing

    Created on
    6 Feb 2024 •
    by
    Gavin Hooper-Newton
    Total amount of likes 0
    Total amount of comments 1
    Read more about Hepatitis C Point of Care Testing

  • Gavin Hooper-Newton posted

    8 months ago

  • Daniza Contreras commented on EASL Studio S5 E10: Why should d…

    8 months ago
    EASL Studio S5 E10: Why should diabetologists care about the liver?

    EASL Studio S5 E10: Why should diabetologists care about the liver?

    Description In this episode, participants tackle the relationship between metabolic dysfunction-associated steatotic liver diseases (MASLD) and type 2 diabetes (T2D), exploring their prevalence and the potential for more aggressive outcomes. Experts weigh in on the pressing questions of whether non-invasive test thresholds shoul...
    Total amount of likes 1
    Total amount of comments 1
    Read more about EASL Studio S5 E10: Why should diabetologists care about the liver?
    Log in to post comments
    Daniza Contreras
    Daniza Contreras • 8 months ago

    Great

    Like
    1 like
    Dislike 0
    Reply
    Anonymous

  • ABU SALEH MD SADEQUL ISLAM posted

    8 months ago

  • Robert Gish commented on Role of lymphatics in liver dise…

    10 months ago

    • Pagination

    • Next page ››

Community Stream

Easl Community FeedMy Feed
Browse Stream
EASL.EU Home
Home of Hepatology
7 rue Daubin
1203 Geneva
Switzerland

Follow us:

Sign up to EASL News

©2019 - EASL. All Rights Reserved. Powered by Enovation.

Footer menu

  • Privacy Policy
  • Cookie Policy